These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 1871038)
21. Delivery of glucocorticoid conjugate in rat gastrointestinal tract and its treatment for ulcerative colitis. Zhou SY; Mei QB; Liu L; Guo X; Qiu BS; Zhao DH; Cho CH Acta Pharmacol Sin; 2001 Aug; 22(8):761-4. PubMed ID: 11749853 [TBL] [Abstract][Full Text] [Related]
22. Macromolecular prodrugs. XVI. Colon-targeted delivery--comparison of the rate of release of naproxen from dextran ester prodrugs in homogenates of various segments of the pig gastrointestinal (GI) tract. Larsen C; Harboe E; Johansen M; Olesen HP Pharm Res; 1989 Dec; 6(12):995-9. PubMed ID: 2622863 [TBL] [Abstract][Full Text] [Related]
23. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: steady-state pharmacokinetics in the rat. McLeod AD; Tolentino L; Tozer TN Biopharm Drug Dispos; 1994 Mar; 15(2):151-61. PubMed ID: 7516722 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of sulfate conjugated metronidazole as a colon-specific prodrug of metronidazole. Kim H; Lee Y; Yoo H; Kim J; Kong H; Yoon JH; Jung Y; Kim YM J Drug Target; 2012 Apr; 20(3):255-63. PubMed ID: 22118327 [TBL] [Abstract][Full Text] [Related]
26. Sulfate-conjugated methylprednisolone: evaluation as a colon-specific methylprednisolone prodrug and comparison with sulfate-conjugated prednisolone and dexamethasone. Kong H; Kim Y; Lee Y; Choi B; Jung S; Jung Y; Kim YM J Drug Target; 2009 Feb; 17(2):159-67. PubMed ID: 18988065 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of indomethacin ester prodrugs: gastrointestinal and hepatic toxicity and the hydrolytic capacity of various tissues in rats. Ogiso T; Iwaki M; Tanino T; Nagai T; Ueda Y; Muraoka O; Tanabe G Biol Pharm Bull; 1996 Sep; 19(9):1178-83. PubMed ID: 8889037 [TBL] [Abstract][Full Text] [Related]
28. Steady-state pharmacokinetics of corticosteroid delivery from glucuronide prodrugs in normal and colitic rats. Nolen HW; Fedorak RN; Friend DR Biopharm Drug Dispos; 1997 Nov; 18(8):681-95. PubMed ID: 9373725 [TBL] [Abstract][Full Text] [Related]
29. Colon-specific delivery of celecoxib is a potential strategy to improve toxicological and pharmacological properties of the selective Cox-2 inhibitor: implication in treatment of familiar adenomatous polyposis. Lee Y; Kim H; Kim W; Yoon JH; Jeong SH; Jung Y J Drug Target; 2012 Jul; 20(6):524-34. PubMed ID: 22632102 [TBL] [Abstract][Full Text] [Related]
30. [Characteristics of drug-release in vitro of different dextran-dexamethasone conjugates]. Zhou SY; Mei QB; Liu L; Zhang BL; Li C; Zhou J Yao Xue Xue Bao; 2003 May; 38(5):388-91. PubMed ID: 12958847 [TBL] [Abstract][Full Text] [Related]
31. Pharmaceutical approaches to colon targeted drug delivery systems. Chourasia MK; Jain SK J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729 [TBL] [Abstract][Full Text] [Related]
32. Colonic delivery of dexamethasone: a pharmacoscintigraphic evaluation. Kenyon CJ; Nardi RV; Wong D; Hooper G; Wilding IR; Friend DR Aliment Pharmacol Ther; 1997 Feb; 11(1):205-13. PubMed ID: 9042995 [TBL] [Abstract][Full Text] [Related]
33. Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery. Lee Y; Kim J; Kim W; Nam J; Jeong S; Lee S; Yoo JW; Kim MS; Jung Y Drug Des Devel Ther; 2015; 9():4105-13. PubMed ID: 26251576 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of 5-aminosalicyl-glycine as a potential colon-specific prodrug of 5-aminosalicylic acid. Jung YJ; Lee JS; Kim HH; Kim YM; Han SK Arch Pharm Res; 1998 Apr; 21(2):174-8. PubMed ID: 9875427 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and in vitro/in vivo evaluation of 5-aminosalicyl-glycine as a colon-specific prodrug of 5-aminosalicylic acid. Jung YJ; Lee JS; Kim YM J Pharm Sci; 2000 May; 89(5):594-602. PubMed ID: 10756325 [TBL] [Abstract][Full Text] [Related]
36. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment. El-Kamel AH; Abdel-Aziz AA; Fatani AJ; El-Subbagh HI Int J Pharm; 2008 Jun; 358(1-2):248-55. PubMed ID: 18502065 [TBL] [Abstract][Full Text] [Related]
37. Effect of antibiotic pretreatment on glycoside/glycosidase-based colonic drug delivery. Friend DR; Chow JJ; Chang GW Drug Des Deliv; 1990 Oct; 6(4):311-8. PubMed ID: 2083030 [TBL] [Abstract][Full Text] [Related]
38. Hydrolysis of pyridoxine-5'-beta-D-glucoside by a broad-specificity beta-glucosidase from mammalian tissues. Trumbo PR; Banks MA; Gregory JF Proc Soc Exp Biol Med; 1990 Nov; 195(2):240-6. PubMed ID: 2122467 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and in vitro properties of prednisolone 21-sulfate sodium as a colon-specific prodrug of prednisolone. Doh MJ; Jung YJ; Kim Ih; Kong HS; Kim YM Arch Pharm Res; 2003 Apr; 26(4):258-63. PubMed ID: 12735681 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and properties of polysaccharide prodrugs of 5-aminosalicylic acid as potential colon-specific delivery systems. Zou M; Okamoto H; Cheng G; Hao X; Sun J; Cui F; Danjo K Eur J Pharm Biopharm; 2005 Jan; 59(1):155-60. PubMed ID: 15567313 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]